
Brawn Biotech Ltd Hits New 52-Week High of Rs 26.64 on Back of Strong Technical Signals
2026-10-28 10:43:03From a 52-week low of Rs 17.71 to a fresh high of Rs 26.64, Brawn Biotech Ltd has delivered a 33.2% gain over the past year, significantly outperforming the Sensex which declined 14% in the same period. This rally, culminating in a new 52-week peak on 28 Oct 2026, is underpinned by a broad alignment of technical indicators signalling sustained momentum.
Read More
Broad-Based Technical Strength Lifts Brawn Biotech Ltd to 52-Week High of Rs 25.7
2026-10-06 10:35:14Surging to a fresh 52-week high of Rs 25.7 on 6 Oct 2026, Brawn Biotech Ltd has demonstrated notable price momentum, outperforming its sector despite a modest underperformance on the day. This milestone caps a year-long rally that has delivered a 14.22% return, comfortably ahead of the Sensex’s 11.13% decline over the same period.
Read More
Broad-Based Technical Strength Lifts Brawn Biotech Ltd to 52-Week High of Rs 24.74
2026-10-01 10:43:26With a decisive surge to Rs 24.74 on 1 Oct 2026, Brawn Biotech Ltd has reached a fresh 52-week high, marking a notable milestone in its price momentum. This rally has been fuelled by a confluence of bullish technical indicators and sustained gains over the past three sessions, even as the broader market struggles to find footing.
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
07-Nov-2026 | Source : BSENEWSPAPER PUBLICATION FOR UN-AUDITED FINANCIAL RESULTS FOR QUARTER AND HALF YEAR ENDED 30TH SEP 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On 5Th November 2026 To Consider And Approve Inter-Alia Un-Audited Financial Results Of The Company For Quarter Ended September 30 2026.
05-Nov-2026 | Source : BSEOutcome Of Board Meeting Held On 5th November 2026 To Consider And Approve Inter-Alia Un-Audited Financial Results Of The Company For Quarter Ended September 30 2026.
Intimation Regarding Non-Applicability Of Regulation 23(9)
05-Nov-2026 | Source : BSEIntimation regarding non-applicability of regulation 23(9)
Corporate Actions
No Upcoming Board Meetings
Brawn Biotech Ltd has declared 10% dividend, ex-date: 12 Sep 18
No Splits history available
No Bonus history available
No Rights history available